Amersham Pharmacia Biotech Acquiring Molecular Dynamics
Executive Summary
Amersham Pharmacia Biotech expects its $256 mil. acquisition of Molecular Dynamics to increase sales and distribution opportunities for Molecular's MegaBACE 1000 high-throughput DNA sequencer and create a viable threat to market leader Perkin-Elmer.